Introduction
The purpose of these guidelines is to ensure compliance with the scope and requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 2004/757/JHA (as amended) in respect to the risk assessment procedure for and reporting on new psychoactive substances.
To operationalise the technical aspects of the risk assessment, the guidelines are supported by a set of Guidance notes developed by the EMCDDA. The Guidance notes will be adapted as required in order to reflect developments in the field of new psychoactive substances and risk assessment.
Note on translation
The translations into Spanish were produced with funding from the COPOLAD III project.
Descargo de responsabilidad
Estas traducciones se han realizado con financiación del proyecto COPOLAD III (2024).
Se agradece a Gregorio Planchuelo de EUDA por revisar la traducción. El Reglamento (CE) nº 1920/2006, modificado por el Reglamento (UE) 2017/2101, ya no está en vigor y deberá ser sustituido por el Reglamento (UE) 2023/1322.
Download as PDF
Table of contents
- Introduction and purpose
- Legal basis and scope
- Conceptual framework for risk assessment
- General considerations for risk assessment
- Risk assessment report
- References
Guidance notes
